Literature DB >> 19540340

Structural properties of monoclonal antibody aggregates induced by freeze-thawing and thermal stress.

Andrea Hawe1, Julia Christina Kasper, Wolfgang Friess, Wim Jiskoot.   

Abstract

Aggregation of monoclonal antibodies can be induced by freeze-thawing and elevated temperature, typical stress factors during development, production and storage. Our aim was to characterize structural properties of aggregates formed after freeze-thawing and thermal stressing of humanized monoclonal IgG(1) antibody (IgG). Formulations with 1.0mg/ml IgG in 100mM phosphate pH 7.2 were subjected to freeze-thawing and heating and characterized by spectroscopic techniques (UV-absorption, CD, ATR-FTIR and fluorescence), light obscuration, dynamic light scattering, SDS-PAGE, AF4 with UV and MALLS detection, and HP-SEC with UV and online fluorescent dye detection. Thermal stress led to an increased formation of dimers and soluble oligomers (HP-SEC, AF4). Aggregates smaller than 30nm were measured (DLS), next to slightly elevated particle levels in the mum range (light obscuration). Aggregates created by heating were in part covalently linked (SDS-PAGE) and made up of conformationally perturbed monomers (CD, ATR-FTIR, extrinsic dye fluorescence). Aggregation after freeze-thawing was manifested primarily in particle formation in the mum range. These aggregates were noncovalently linked (SDS-PAGE) and composed of native-like monomers, as obvious from CD, ATR-FTIR and extrinsic dye fluorescence spectroscopy. In conclusion, the complementary methods used in this study revealed that heating and freeze-thawing induced aggregates differ significantly in their physico-chemical characteristics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19540340     DOI: 10.1016/j.ejps.2009.06.001

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  52 in total

1.  Structure and function of purified monoclonal antibody dimers induced by different stress conditions.

Authors:  Rajsekhar Paul; Alexandra Graff-Meyer; Henning Stahlberg; Matthias E Lauer; Arne C Rufer; Hermann Beck; Alexandre Briguet; Volker Schnaible; Thomas Buckel; Sabine Boeckle
Journal:  Pharm Res       Date:  2012-04-05       Impact factor: 4.200

2.  The use of native cation-exchange chromatography to study aggregation and phase separation of monoclonal antibodies.

Authors:  Shuang Chen; Hollis Lau; Yan Brodsky; Gerd R Kleemann; Ramil F Latypov
Journal:  Protein Sci       Date:  2010-06       Impact factor: 6.725

3.  Protein G, protein A and protein A-derived peptides inhibit the agitation induced aggregation of IgG.

Authors:  Jun Zhang; Elizabeth M Topp
Journal:  Mol Pharm       Date:  2012-02-09       Impact factor: 4.939

4.  Do bevacizumab solutions interact with silicone or polyurethane catheters during an infusion through implantable venous access ports?

Authors:  Nicolas Tokhadzé; Philip Chennell; Régis Cueff; Valérie Sautou
Journal:  J R Soc Interface       Date:  2019-09-25       Impact factor: 4.118

5.  Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditions.

Authors:  Srivalli N Telikepalli; Ozan S Kumru; Cavan Kalonia; Reza Esfandiary; Sangeeta B Joshi; C Russell Middaugh; David B Volkin
Journal:  J Pharm Sci       Date:  2014-01-22       Impact factor: 3.534

6.  A new approach to explore the impact of freeze-thaw cycling on protein structure: hydrogen/deuterium exchange mass spectrometry (HX-MS).

Authors:  Aming Zhang; Wei Qi; Satish K Singh; Erik J Fernandez
Journal:  Pharm Res       Date:  2011-02-08       Impact factor: 4.200

Review 7.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

Review 8.  The importance of handling high-value biologicals: Physico-chemical instability and immunogenicity of monoclonal antibodies.

Authors:  Tomislav Laptoš; Jasna Omersel
Journal:  Exp Ther Med       Date:  2018-01-31       Impact factor: 2.447

9.  Structural analysis of a therapeutic monoclonal antibody dimer by hydroxyl radical footprinting.

Authors:  Galahad Deperalta; Melissa Alvarez; Charity Bechtel; Ken Dong; Ross McDonald; Victor Ling
Journal:  MAbs       Date:  2012-12-17       Impact factor: 5.857

10.  Influence of the valine zipper region on the structure and aggregation of the basic leucine zipper (bZIP) domain of activating transcription factor 5 (ATF5).

Authors:  Natalie A Ciaccio; T Steele Reynolds; C Russell Middaugh; Jennifer S Laurence
Journal:  Mol Pharm       Date:  2012-10-23       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.